BioMarin Pharmaceuticals Inc (BMRN) — Analysis Summary
BioMarin Pharmaceuticals Inc (BMRN) has a market cap of $11.07B with year-over-year revenue growth of +12.9%. Net margin stands at 10.8%. The stock trades at a P/E ratio of 41.2.
Key Takeaways
- Revenue changed +12.9% year-over-year
- Net margin of 10.8%
- P/E ratio of 41.2
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, BMRN posted revenue growth of +12.9% and trades at a P/E of 41.2.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.